The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $64.68

Today's change-0.94 -1.43%
Updated July 26 11:54 AM EDT. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $64.68

Today's change-0.94 -1.43%
Updated July 26 11:54 AM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

NU Skin Enterprises Inc is lower today, dropping (U.S.)$0.94 or 1.43% to (U.S.)$64.68 after setting a new 100-day high. Over the last five days, shares have gained 1.75% and are currently 2.06% off of the 52-week high. Shares have outperformed the S&P 500 by 9.22% during the last year.

Key company metrics

  • Open(U.S.) $65.62
  • Previous close(U.S.) $65.62
  • High(U.S.) $65.65
  • Low(U.S.) $64.27
  • Bid / Ask(U.S.) $64.69 / (U.S.) $64.74
  • YTD % change+35.37%
  • Volume125,614
  • Average volume (10-day)397,146
  • Average volume (1-month)515,504
  • Average volume (3-month)616,201
  • 52-week range(U.S.) $46.35 to (U.S.) $66.04
  • Beta1.35
  • Trailing P/E21.68×
  • P/E 1 year forward21.01×
  • Forward PEG2.47×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield2.23%
  • Trailing EPS(U.S.) $2.98
Updated July 26 11:54 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.48%

Based on its net profit margin of 7.48%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue499531604600
Total other revenue--------
Total revenue499531604600
Gross profit388423478472
Total cost of revenue111109126128
Total operating expense453471522521
Selling / general / administrative342362396392
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income46618280
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax42627769
Income after tax27385745
Income tax, total14242024
Net income27385745
Total adjustments to net income--------
Net income before extra. items27385745
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items27385745
Inc. avail. to common incl. extra. items27385745
Diluted net income27385745
Dilution adjustment--------
Diluted weighted average shares54555856
Diluted EPS excluding extraordinary itemsvalue per share0.510.700.980.79
Dividends per sharevalue per share0.360.360.360.36
Diluted normalized EPSvalue per share0.510.700.980.79